Cargando…
An Agonistic Anti-CD137 Antibody Disrupts Lymphoid Follicle Structure and T-Cell-Dependent Antibody Responses
CD137 is a costimulatory receptor expressed on natural killer cells, T cells, and subsets of dendritic cells. An agonistic monoclonal antibody (mAb) against CD137 has been used to reduce tumor burden or reverse autoimmunity in animal models and clinical trials. Here, we show that mice treated with a...
Autores principales: | Hong, Jun P., Reynoso, Glennys V., Andhey, Prabhakar S., Swain, Amanda, Turner, Jackson S., Boon, Adrianus C.M., Krammer, Florian, Ellebedy, Ali H., Zanini, Fabio, Artyomov, Maxim, Hickman, Heather D., Diamond, Michael S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375459/ https://www.ncbi.nlm.nih.gov/pubmed/32699843 http://dx.doi.org/10.1016/j.xcrm.2020.100035 |
Ejemplares similares
-
Comparative evaluation of itaconate and its derivatives reveals
divergent inflammasome and type I interferon regulation in
macrophages
por: Swain, Amanda, et al.
Publicado: (2020) -
The lymphoid follicle variant of dermatomyositis
por: Radke, Josefine, et al.
Publicado: (2014) -
An Update on Anti-CD137 Antibodies in Immunotherapies for Cancer
por: Chu, Dinh-Toi, et al.
Publicado: (2019) -
Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies
por: Glez-Vaz, Javier, et al.
Publicado: (2022) -
Detection of Bourbon Virus-Specific Serum Neutralizing Antibodies in Human Serum in Missouri, USA
por: Bamunuarachchi, Gayan, et al.
Publicado: (2022)